SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Commercial Influence and Global Nongovernmental Public Action in Health and Pharmaceutical Policies
16 references·1 citing·38 second hop
Commercial Influence and Global Nongovernmental Public Action in Health and Pharmaceutical Policies (2011)Commercial Influence and Global Nongovern…Global Pharmaceutical Markets and Corporate Citizenship: The Case of Novartis’ Anti-cancer Drug Glivec (2008)Global Pharmaceutical Markets…Inclusion without Influence? NGOs in European Trade Policy (2007)Inclusion without Influence? …Evolution of Antiretroviral Drug Costs in Brazil in the Context of Free and Universal Access to AIDS Treatment (2007)Evolution of Antiretroviral D…All Politics Is Global: Explaining International Regulatory Regimes (2007)All Politics Is Global: Expla…Seven habits of highly effective global public–private health partnerships: Practice and potential (2006)Seven habits of highly effect…Is access to essential medicines as part of the fulfilment of the right to health enforceable through the courts? (2006)Is access to essential medici…Using Ideas Strategically: The Contest Between Business and NGO Networks in Intellectual Property Rights (2004)Using Ideas Strategically: Th…Restructuring World Politics: Transnational Social Movements, Networks, and Norms (2002)Restructuring World Politics:…Developing Countries and International Intellectual Property Standard‐Setting (2002)Developing Countries and Inte…Do Patents for Antiretroviral Drugs Constrain Access to AIDS Treatment in Africa? (2001)Do Patents for Antiretroviral…The development of international health policies — accountability intact? (2000)The development of internatio…Global public-private partnerships: Part II--What are the health issues for global governance? (2000)Global public-private partner…Global public-private partnerships: Part I--A new development in health? (2000)Global public-private partner…Global Business Regulation (2000)Global Business RegulationGlobalization, Pharmaceutical Pricing, and South African Health Policy: Managing Confrontation with U.S. Firms and Politicians (1999)Globalization, Pharmaceutical…Activists beyond Borders: Advocacy Networks in International Politics (1998)Activists beyond Borders: Adv…Exploring public private partnerships in health and education: a critique (2017)Exploring public private part…The Logic of Collective Action. (1966)Lobbying as Legislative Subsidy (2006)Measuring Interest Group Influence in the EU (2008)Case Study and Theory in Political Science (2009)Gaining access or going public? Interest group strategies in five European countries (2013)Interest Group Success in the European Union (2015)The selection and use of essential medicines. (2004)History, principles, and practice of health and human rights (2007)The judicialization of biopolitics: Claiming the right to pharmaceuticals in Brazilian courts (2013)The Iron Cage Revisited: Institutional Isomorphism and Collective Rationality in Organizational Fields (1983)Economic Action and Social Structure: The Problem of Embeddedness (1985)Power in global governance (2004)The iron cage revisited institutional isomorphism and collective rationality in organizational fields (2004)The Marketing of Rebellion (2005)Political Contestation in Global Production Networks (2008)Power: A Radical View (1974)Theory of International Politics, by Kenneth N. Waltz (1980)Diplomacy and domestic politics: the logic of two-level games (1988)The New Transnational Activism (2005)Transnational Human Rights and Local Activism: Mapping the Middle (2006)Putting the S back in corporate social responsibility: A multilevel theory of social change in organizations (2007)The introduction of new vaccines into developing countries (1999)Public–private Partnerships for Health: A trend with no alternatives? (2004)Public–private partnerships ( ppp s) in global health: the good, the bad and the ugly (2014)Global health funding: how much, where it comes from and where it goes (2009)Transnational Public-Private Partnerships in International Relations: Making Sense of Concepts, Research Frameworks, and Results (2009)Gender equality in science, medicine, and global health: where are we at and why does it matter? (2019)Public-private health partnerships: a strategy for WHO. (2001)Governance: What Do We Know, and How Do We Know It? (2016)Toward a political conception of corporate responsibility: Business and society seen from a habermasian perspective (2007)The New Political Role of Business in a Globalized World: A Review of a New Perspective on CSR and its Implications for the Firm, Governance, and Democracy (2010)The Regime Complex for Climate Change (2011)Beyond Constitutionalism (2010)The Contentiousness of Markets: Politics, Social Movements, and Institutional Change in Markets (2010)Market power Europe (2012)Beyond “identity” (2000)Why would corporations behave in socially responsible ways? an institutional theory of corporate social responsibility (2007)THE LOGIC OF CONNECTIVE ACTION (2012)
this work references cited by second hop

References

  • 1998Activists beyond Borders: Advocacy Networks in International Politics3,738 cited
  • 2000Global Business Regulation1,784 cited
  • 2002Restructuring World Politics: Transnational Social Movements, Networks, and Norms819 cited
  • 2007All Politics Is Global: Explaining International Regulatory Regimes597 cited
  • 2004Using Ideas Strategically: The Contest Between Business and NGO Networks in Intellectual Property Rights493 cited
  • 2000Global public-private partnerships: Part I--A new development in health?362 cited
  • 2006Seven habits of highly effective global public–private health partnerships: Practice and potential348 cited
  • 2007Inclusion without Influence? NGOs in European Trade Policy315 cited
  • 2006Is access to essential medicines as part of the fulfilment of the right to health enforceable through the courts?253 cited
  • 2000Global public-private partnerships: Part II--What are the health issues for global governance?227 cited
  • 2002Developing Countries and International Intellectual Property Standard‐Setting193 cited
  • 2001Do Patents for Antiretroviral Drugs Constrain Access to AIDS Treatment in Africa?169 cited
  • 2008Global Pharmaceutical Markets and Corporate Citizenship: The Case of Novartis’ Anti-cancer Drug Glivec166 cited
  • 1999Globalization, Pharmaceutical Pricing, and South African Health Policy: Managing Confrontation with U.S. Firms and Politicians

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

157 cited
  • 2007Evolution of Antiretroviral Drug Costs in Brazil in the Context of Free and Universal Access to AIDS Treatment142 cited
  • 2000The development of international health policies — accountability intact?139 cited
  • Cited by

    • 2017Exploring public private partnerships in health and education: a critique23 cited